Athero-protective Effects of High Density Lipoproteins (HDL): An ODE Model of the Early Stages of Atherosclerosis

The AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Trial

(2012) Stephen J. Nicholls   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Diet-Induced Weight Loss in Overweight or Obese Women and Changes in High-Density Lipoprotein Levels and Function

(2012) Brittany O. Aicher et al.   Obesity

HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells

(2011) J. E. Feig et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

An ODE Model of Early Stages of Atherosclerosis: Mechanisms of the Inflammatory Response

(2010) Anna Ougrinovskaia et al.   BULLETIN OF MATHEMATICAL BIOLOGY

HDL Therapy for the Treatment of Cardiovascular Diseases

(2009) Cinzia Parolini et al.   Current Vascular Pharmacology

HDL as a Biomarker, Potential Therapeutic Target, and Therapy: FIG. 1.

(2009) Mohamad Navab et al.   DIABETES

HDL therapy for cardiovascular diseases: the road to HDL mimetics

(2008) C. Roger White et al.   Current Atherosclerosis Reports

Transcriptional diversity during monocyte to macrophage differentiation

(2008) Hongtao Liu et al.   IMMUNOLOGY LETTERS

Is raising HDL a futile strategy for atheroprotection?

(2008) Tisha Joy et al.   NATURE REVIEWS DRUG DISCOVERY

Rapid regression of atherosclerosis: insights from the clinical and experimental literature

(2008) Kevin Jon Williams et al.   Nature clinical practice. Cardiovascular medicine